THE QUALITY OF LIFE IN INPATIENTS WITH CHRONIC SCHIZOPHRENIA
Abstract
Background. Whether in the prescription of appropriate types and doses of psychotropic medications or determining readiness for psychosocial treatment and rehabilitation, clinicians must be able to pinpoint, quantify, and monitor the severity of psychiatric symptoms. Brief Psychiatric Rating Scale (BPRS) and LiSkal (Linzer Skala zur Messung der Lebensqualität bei Menschen mit chronischen psychosozialen Problemen) were proved to be reliable assessment tools and were used to quantify phenomenological features of schizophrenia in this study.
Methods. 124 patients (76 male and 48 female) were interviewed in this study having the average age of 57. General information was taken from their case histories and symptoms were evaluated by means of the BPRS (Brief Psychiatric Rating Scale). In addition, LISKAL scale was used to evaluate quality of life and independence of patients. Data was processed and frequencies of categories for attribute variables as well as the average (xav) and standard deviation (SD) for numerical variables were calculated. Finally, 95% confidence limit was calculated.
Results. Logistic regression model consisted of the following variables: living outside institutions in adulthood, working period, physical illness, motor slowing and bizzare delusions. The level of independence, measured with LiSkal scale, was 4 with both sexes. The evaluations of single sections in the questionnaire about the quality of life ranged between 3 and 4. The evaluation of independence correlated with the complex evaluation of the life quality.
Conclusions. Results showed that symptoms of illness (negatively) and general facts (positively) affected the quality of life of patients suffering from chronic schizophrenia.
Downloads
References
Muačević V. Psihijatrija. Zagreb: Medicinska naklada, 1995: 322–48.
Kaplan H, Sadock BJ. Synopsis of psychiatry. Baltimore, Hong Kong, London: Williams & Wilkins, 1991: 320–42.
Svetovna zdravstvena organizacija. Mednarodna klasifikacija bolezni in sorodnih zdravstvenih problemov za statistične namene. Deseta revizija. Ljubljana: Inštitut za varovanje zdravja, 1995: 325–32.
Ciompi L. Learning from outcome studies. Toward a comprehensive biological – psychosocial understanding of schizophrenia. Schizophr Res 1988; 373–84.
Skantze K, Malm U, Denker S, May P, Corrigan P. Comparison of quality of life with standard of living in schizophrenic outpatients. Br Psychiatry 1992; 161: 797–801.
Brownes, Roe M, Lane A et al. Quality of life in schizophrenia: relationship to sociodemographic factors, symptomatology and tardive dyskinesia. Acta Psychiatr Scand 1996; 94: 118–23.
Testa MA, Simonson DC. Assessment of quality at life outcomes. New Eng Med 1996; 334: 835–40.
Awad G. Quality of life of schizophrenic patients on medications and implications for new drug trials. Hosp Community Psychiatry 1992; 43: 262–5.
Lauer G. Ergebnisse der Lebensqualitätsvorschung bei chronisch psychisch Kranken. Psychiatr Prax 1993; 20: 88–90.
Brugha TS, Wing JK, Smith BL. Physical ill health of long-term mentally ill in the community. Is there anunment need? Br J Psychiatry 1989; 155: 777–82.
Meltzer H, Gill B, Petticrew M, Hinds K. Physical complaints, service use and treatment of residents with psychiatric disorders. London: HMSO 1996; 5: 14–7.
Birchwood M, Hallet S, Preston M. Schizophrenia. An integrated approach to research and treatment. London: HMSO 1988: 6–9.
Švab V, Gorše-Muhič M, Mrevlje GV. Duševno bolne osebe. Varovanje zdravja posebnih družbenih skupin v Sloveniji. Ljubljana: Inštitut za varovanje zdravja Republike Slovenije,1996: 183–205.
Meltzer H, Gill B, Petticrew M, Hinds K. The prevalence of psychiatric morbidy among adults living in institutions. OPCS Surveys of Psychiatric Morbidity in Great Britain Bull 1995; 2: 2–11.
Overall JE, Gorham DR. The brief psychiatric rating scale. Psychol Rep 1964; 10: 799–9.
Grausgruber A, Ortmair M, Wegscheider B, Rittmannsberger H. LISKAL (Linzer Skala zur Messung der Lebensqualität bei Menschen mit chronischen psichosozialen Problemen). Linz: Universität der Johannes Kepler. Institut für Soziologie. Pro Mente Infirmis Oberösterreich. Landes-Nervenklinik Wagner-Jauregg, 1993.
Adamič Š. Temelji biostatistike. Ljubljana: Medicinska fakulteta, 1980: 75–113.
Lyons JS, O’Mahoney TM et al. Predicting readmission to the psychiatric hospital in a managed care environment: Implications for quality indicators. Am Psychiatry 1997; 154: 337–40.
McCreadie RG. The Nithsdale schizophrenia surveys. An overview. Soc Psychiatric Psychiatr Epidemiol 1992; 27: 40–5.
Allebeck P, Wisted B. Mortality in schizophrenia: A ten year follow-up based on the Stockholm Country inpatients register. Arch Gen Psychiatry 1986; 43: 650–3.
Röder-Wanner U, Priebe S. Schizophrenie und Lebensqualitätgeschlechtsspezifische Aspekte. Fortschritte Neuro Psychiatr 1995; 63: 393–401.
Andreasen NC, Arndt S, Alliger R, Miller D, Flaum M. Symptoms of schizophrenia. Methods, meaning and mechanismus. Arc Gen Psychiatry 1995; 52: 341–51.
Bellac AS, Morrison RL, Wixted JT, Mueser KT. An analysis of social competence in schizophrenia. Br J Psychiatry 1990; 156: 809–18.
Waddington JL, Youssef HA, Dolphin C, Kinsella A. Cognitive dysfunction, negative symptoms and tardive dyskinesia in schizophrenia. Am Psychiatry 1987; 4: 907–12.
Schooler NR. Deficit symptoms in schizophrenia: negative symptoms versus neuroleptic-induces deficits. Acta Psychiatr Scand 1994; 89: Suppl 380: 21–6.
The Author transfers to the Publisher (Zdravniški vestnik/Slovenian Medical Journal) all economic copyrights following form Article 22 of the Slovene Copyright and Related Rights Act (ZASP), including the right of reproduction, the right of distribution, the rental right, the right of public performance, the right of public transmission, the right of public communication by means of phonograms and videograms, the right of public presentation, the right of broadcasting, the right of rebroadcasting, the right of secondary broadcasting, the right of communication to the public, the right of transformation, the right of audiovisual adaptation and all other rights of the author according to ZASP.
The aforementioned rights are transferred non-exclusively, for an unlimited number of editions, for the term of the statutory
The Author can make use of his work himself or transfer subjective rights to others only after 3 months from date of first publishing in the journal Zdravniški vestnik/Slovenian Medical Journal.
The Publisher (Zdravniški vestnik/Slovenian Medical Journal) has the right to transfer the rights, acquired parties without explicit consent of the Author.
The Author consents that the Article be published under the Creative Commons BY-NC 4.0 (attribution-non-commercial) or comparable licence.
